Spanish pharmaceutical market development

Spanish pharma trade group Farmaindustria’s general assembly gathered in Madrid last week to hold an extraordinary session in which it appointed Antoni Esteve as the new president of the Association for the next two years.

Mr Esteve, president of Isdin, part of the his family's Esteve pharmaceutical group, takes over from Elvira Sanz in this position, in accordance with the rules laid down in Farmaindustria Statutes which establish the rotation between companies of Spanish origin and foreigner Co’s for presidency; in this occasion, the former.

During the Assembly, in which the new executive committee and board of directors of the association were also constituted, the current situation of the pharmaceutical industry in Spain was analyzed and it was mentioned that such an intensive R&D sector - as is the pharmaceutical sector - that exports and creates great economical value should never grow below the values of the country as a whole.